Educate About Nirsevimab to Prevent RSV
October 2023
You’ll hear buzz about nirsevimab (Beyfortus) to prevent respiratory syncytial virus (RSV) in young children.
RSV circulation typically peaks from fall to early spring.
Educate that by age 2 most kids will have experienced an RSV infection. Although symptoms are typically mild, even otherwise healthy children can be hospitalized for a serious RSV infection.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive